Connect Education Workshops About Genomics

Upcoming Workshops

There are no upcoming workshops

Past workshops

For All Cancers

1. What’s New in Precision Medicine
   Tags:

   biomarkerscar t-cell therapydiagnostic testsgeneticsgenomicsimmunotherapypersonalized medicinetargeted treatments
2. Understanding Diagnostic Technologies and Biomarkers
   Tags:

   biomarkersdiagnostic testsgenomicspersonalized medicinetargeted treatmentstreatment
3. Understanding How Health Care Disparities May Influence Your Cancer Treatment and Care: With Tips and Strategies to Find the Best Cancer Treatment and Health Care Team for YouPart I of How Health Care Disparities May Influence Your Cancer Treatment and Care
   Tags:

   biomarkersblack or african americandoctor-patient communicationgenomicsside effectstreatmenthealth care professionalslgbtq+health care disparities

For Breast Cancer

1. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
   Tags:

   breast cancermetastatic breast cancertriple negative breast cancerclinical trialsdoctor-patient communicationgeneticsgenomicsmastectomyside effectstreatment
2. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
3. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatments

For Cutaneous T-Cell Lymphoma

1. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
2. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatments

For Diffuse Large B-Cell Lymphoma

1. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
2. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatments

For Follicular Lymphoma

1. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
2. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatments

For Hodgkin Lymphoma

1. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
2. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatments

For Lung Cancer

1. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
2. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatments

For Lymphoma

1. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
2. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatments

For Mantle Cell Lymphoma

1. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
2. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatments

For Marginal Zone Lymphoma

1. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
2. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatments

For Melanoma

1. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatments

For Metastatic Breast Cancer

1. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
   Tags:

   breast cancermetastatic breast cancertriple negative breast cancerclinical trialsdoctor-patient communicationgeneticsgenomicsmastectomyside effectstreatment
2. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
3. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatments

For Non-Hodgkin Lymphoma

1. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
2. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatments

For Peripheral T-Cell Lymphoma

1. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
2. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatments

For Small Lymphocytic Lymphoma

1. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
2. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatments

For Triple Negative Breast Cancer

1. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
   Tags:

   breast cancermetastatic breast cancertriple negative breast cancerclinical trialsdoctor-patient communicationgeneticsgenomicsmastectomyside effectstreatment
2. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapyside effectstargeted treatmentstreatmentpersonalized medicine
3. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
   Tags:

   breast cancercutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomalung cancerlymphomamantle cell lymphomamarginal zone lymphomamelanomametastatic breast cancernon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatriple negative breast cancerbiomarkersclinical trialsgenomicsimmunotherapypersonalized medicineside effectstreatmenttargeted treatments